Topics
High-grade gliomas | Treatment | Immunotherapy | Overview
Home > Publications > Topics > High-grade gliomas > Treatment > Immunotherapy > Overview
Palavani LB, Mitre LP, Camerotte R, Nogueira BV, Canto GL, Chen
HC, Pacheco-Barrios N, Ferreira MY, Batista S, Andreão FF,
Polverini AD, Montenegro TS, Paiva W, Ferreira C, Bertani R,
D'Amico RS.
Advancements and
challenges: immunotherapy therapy in high-grade glioma - a
meta-analysis of randomized clinical trials.
J
Neurooncol. 2024 Sep 4. doi:
10.1007/s11060-024-04813-0. PMID:
39230804. Review˰ ˍ
Karbhari N, Frechette KM, Burns TC, Parney IF, Campian JL, Breen
WG, Sener UT, Lehrer EJ.
Immunotherapy
for High-Grade Gliomas.
Cancers
(Basel). 2025 May 31;17(11):1849. doi:
10.3390/cancers17111849. PMID:
40507329. Review. ˍ
Hsueh B, Steuart SJ, Odukoya AO, Prager BC, Kim YJ, Hill CM, Choi
BD, Dunn GP.
Immunotherapy and
targeted therapy for high grade gliomas: current and future
directions.
J
Neurooncol. 2025 Dec 9;176(1):112. doi:
10.1007/s11060-025-05315-3. PMID:
41366148. Review˰ ˍ